The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...

If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...

There's been an all-out push by the drug regulators and media to get every adult and child on Ozempic, a drug which causes temporary weight loss and harms the majority of recipients. Here, two leading ...

Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...

Health officials have issued yet another warning over the perils of fake weight loss jabs after an influencer nearly died ...

China’s drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...

Novo Nordisk, GSK and others need to replenish their pipelines to replace drugs coming off patent. In the past, buying a promising biotech required paying a 100% premium. But high interest rates and ...

The Securities and Exchange Commission, overseen by crypto millionaire Paul Atkins, just agreed to drop its lawsuit against ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...

A groundbreaking initiative from the Trump administration could revolutionize access to costly weight-loss drugs under ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...

Tirzepatide (GIP + GLP-1) has also been shown to reduce cardiovascular risk. In an international trial of 713 adults in nine ...